NeoPhore appoints Michael Shih as Chief Executive Officer
Highly experienced corporate development leader with a track record of international pharma and biotech deal-makingNew CEO to drive growth strategy to maximise...
Day: December 16, 2024
Promise Bio Emerges from Stealth with $8.3M Seed Investment to Transform Precision Medicine for Immune-Mediated Diseases
Company unveils breakthrough platform that integrates epiproteomics and AI to identify predictive biomarkers for personalized treatments and support drug development...
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU PatientsResults Expected to Promote Awareness and Adoption of PKU...
Seoul to Host 1,040㎡ ‘Seoul Pavilion’ at CES 2025: “Advancing Global Success for Seoul Startups”
SEOUL, South Korea, Dec. 15, 2024 /PRNewswire/ -- The Seoul Metropolitan Government announced on December 9 that it will operate its...